News
Smith+Nephew (NYSE: SNN) today announced new evidence highlighting the clinical performance of its Regeneten bioinductive implant.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback